Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Grant of Share Options

1 Mar 2019 13:18

RNS Number : 6303R
PCI-PAL PLC
01 March 2019
 

 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

 

Grant of Share Options

 

PCI-PAL PLC (AIM: PCIP), the customer engagement specialist that secures and protects payment card data for companies handling payments by phone, today announces that it has granted options ("Options") over ordinary shares of 1 pence each ("Ordinary Shares") to a person disclosing managerial responsibilities ("PDMR").

 

Darren Gill, who was recently promoted to the position of Chief Revenue Officer (CRO) in the Company and is therefore a PDMR, has been granted 100,000 Options (the "PDMR Grant") as follows:

 

Name

Title

Options granted

Date of Grant

Earliest Vesting date

Darren Gill

CRO

100,000

28/02/2019

27/07/2019

 

Following the PDMR Grant, Darren Gill holds options over 250,000 Ordinary Shares.

 

In addition, he owns a total of 100,000 Ordinary Shares, representing 0.2% the current issued share capital of the Company. 

 

Further information is set out in the FCA Disclosure table below.

 

Terms of the Options

The exercise price is 23.0 pence per Ordinary Share, being the closing mid-market price published by the London Stock Exchange on 27 February 2019, and the Options will vest over a four-year period subject to the recipient having remained in continuous employment prior to any exercising of Options.

 

The terms of vesting are as follows:

 

Tranche of award

Vesting Criteria

10,416 Options

Shall vest on the 27 July 2019 being 5 months from the date of issue

89,584 Options

Shall vest in equal monthly tranches over a period of 43 months starting on the 27 August 2019

 

Following this announcement, there is a total of 5,111,667 options over Ordinary Shares, representing 11.97% of the current issued share capital of the Company.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Geoff Nash/Marc Milmo/Simon Hicks

(Corporate Finance)

 

Richard Chambers (Corporate Broking)

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Paul Vann

+44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a specialist provider of secure payment solutions for contact centres and businesses taking Cardholder Not Present (CNP) payments. PCI Pal's globally accessible cloud platform empowers organisations to take payments securely without bringing their environments into scope of PCI DSS and other card payment data security rules and regulations.

 

With the entire product portfolio served from PCI Pal's cloud environment, integrations with existing telephony, payment, and desktop environments are light-touch, ensuring no degradation of service while achieving security and compliance.

 

PCI Pal has offices in London, Ipswich (UK) and Charlotte NC (USA). For more information visit www.pcipal.com or follow the team on Twitter: https://twitter.com/PCIPAL

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Darren Gill

2.

Reason for the notification

a)

Position/status:

Chief Revenue Officer / PDMR

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

PCI PAL PLC

b)

LEI:

213800XTX34IQYMYES95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary shares of 1 pence each

 

ISIN Code: GB0009737155

b)

Nature of the transaction:

 Grant of Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

23 pence

100,000

 

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

27 February 2019

f)

Place of the transaction:

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSIFDFFUSEFD
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.